Identification of multipotent mesenchymal stromal cells in the reactive stroma of a prostate cancer xenograft by side population analysis

Experimental Cell Research

Volumn 315, Issue 17, 2009, Pages 3004-3013

  Santamaria Martínez, Albert ^a,b   Barquinero, Jordi ^a,c,d   Barbosa Desongles, Anna ^a,c   Hurtado, Antoni ^a,c   Pinós, Tomàs ^a,c   Seoane, Joan ^a,c,e,f   Poupon, Marie France ^g   Morote, Joan ^a,c   Reventós, Jaume ^a,c   Munell, Francina ^a,c  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

^c UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^d BANC DE SANG I TEIXITS   (Spain)

^e VALL D HEBRON UNIVERSITY HOSPITAL   (Spain)

^f INSTITUCIÓ CATALANA DE RECERCA I ESTUDIS AVANÇATS ICREA   (Spain)

^g INSTITUT CURIE   (France)

Author keywords

Multipotent mesenchymal stromal cell; Prostate cancer; Side population; Stroma; Transforming growth factor

Indexed keywords

CD45 ANTIGEN; CD81 ANTIGEN; HOE 33342; STEM CELL ANTIGEN 1; TRANSFORMING GROWTH FACTOR BETA1;

ADIPOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE DEVELOPMENT; CANCER CELL CULTURE; CELL ADHESION; CELL ASSAY; CELL CLONE; CELL DIFFERENTIATION; CELL ISOLATION; CELL PROLIFERATION; CELL SELECTION; CELL STRUCTURE; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; MALE; MESENCHYMAL STEM CELL; MITOSIS INHIBITION; MOUSE; MULTIPOTENT STEM CELL; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN SECRETION; STROMA CELL; TUMOR XENOGRAFT;

MURINAE;

EID: 70349595100     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2009.05.007     Document Type: Article

References (50)

1. da Silva Meirelles L., Chagastelles P.C., and Nardi N.B. Mesenchymal stem cells reside in virtually all post-natal organs and tissues. J. Cell Sci. 119 (2006) 2204-2213
2. Wagner W., and Ho A.D. Mesenchymal stem cell preparations-comparing apples and oranges. Stem Cell Rev. 3 (2007) 239-248
3. Dominici M., Le Blanc K., Mueller I., Slaper-Cortenbach I., Marini F., Krause D., Deans R., Keating A., Prockop D., and Horwitz E. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8 (2006) 315-317
4. Baddoo M., Hill K., Wilkinson R., Gaupp D., Hughes C., Kopen G.C., and Phinney D.G. Characterization of mesenchymal stem cells isolated from murine bone marrow by negative selection. J. Cell. Biochem. 89 (2003) 1235-1249
5. Liechty K.W., MacKenzie T.C., Shaaban A.F., Radu A., Moseley A.M., Deans R., Marshak D.R., and Flake A.W. Human mesenchymal stem cells engraft and demonstrate site-specific differentiation after in utero transplantation in sheep. Nat. Med. 6 (2000) 1282-1286
6. Ohlsson L.B., Varas L., Kjellman C., Edvardsen K., and Lindvall M. Mesenchymal progenitor cell-mediated inhibition of tumor growth in vivo and in vitro in gelatin matrix. Exp. Mol. Pathol. 75 (2003) 248-255
7. Pisati F., Belicchi M., Acerbi F., Marchesi C., Giussani C., Gavina M., Javerzat S., Hagedorn M., Carrabba G., Lucini V., Gaini S.M., Bresolin N., Bello L., Bikfalvi A., and Torrente Y. Effect of human skin-derived stem cells on vessel architecture, tumor growth, and tumor invasion in brain tumor animal models. Cancer Res. 67 (2007) 3054-3063
8. Jian H., Shen X., Liu I., Semenov M., He X., and Wang X.F. Smad3-dependent nuclear translocation of beta-catenin is required for TGF-beta1-induced proliferation of bone marrow-derived adult human mesenchymal stem cells. Genes Dev. 20 (2006) 666-674
9. Ng F., Boucher S., Koh S., Sastry K.S., Chase L., Lakshmipathy U., Choong C., Yang Z., Vemuri M.C., Rao M.S., and Tanavde V. PDGF, TGF-beta, and FGF signaling is important for differentiation and growth of mesenchymal stem cells (MSCs): transcriptional profiling can identify markers and signaling pathways important in differentiation of MSCs into adipogenic, chondrogenic, and osteogenic lineages. Blood 112 (2008) 295-307
10. Massague J., Seoane J., and Wotton D. Smad transcription factors. Genes Dev. 19 (2005) 2783-2810
11. Verona E.V., Elkahloun A.G., Yang J., Bandyopadhyay A., Yeh I.T., and Sun L.Z. Transforming growth factor-beta signaling in prostate stromal cells supports prostate carcinoma growth by up-regulating stromal genes related to tissue remodeling. Cancer Res. 67 (2007) 5737-5746
12. Goodell M.A., Brose K., Paradis G., Conner A.S., and Mulligan R.C. Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo. J. Exp. Med. 183 (1996) 1797-1806
13. Zhou S., Schuetz J.D., Bunting K.D., Colapietro A.M., Sampath J., Morris J.J., Lagutina I., Grosveld G.C., Osawa M., Nakauchi H., and Sorrentino B.P. The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype. Nat. Med. 7 (2001) 1028-1034
14. Scharenberg C.W., Harkey M.A., and Torok-Storb B. The ABCG2 transporter is an efficient Hoechst 33342 efflux pump and is preferentially expressed by immature human hematopoietic progenitors. Blood 99 (2002) 507-512
15. Challen G.A., and Little M.H. A side order of stem cells: the SP phenotype. Stem Cells (Dayton, Ohio) 24 (2006) 3-12
16. Reya T., Morrison S.J., Clarke M.F., and Weissman I.L. Stem cells, cancer, and cancer stem cells. Nature 414 (2001) 105-111
17. Hirschmann-Jax C., Foster A.E., Wulf G.G., Nuchtern J.G., Jax T.W., Gobel U., Goodell M.A., and Brenner M.K. A distinct "side population" of cells with high drug efflux capacity in human tumor cells. Proc. Natl. Acad. Sci. U.S.A. 101 (2004) 14228-14233
18. Hadnagy A., Gaboury L., Beaulieu R., and Balicki D. SP analysis may be used to identify cancer stem cell populations. Exp. Cell Res. 312 (2006) 3701-3710
19. de Pinieux G., Legrier M.E., Poirson-Bichat F., Courty Y., Bras-Goncalves R., Dutrillaux A.M., Nemati F., Oudard S., Lidereau R., Broqua P., Junien J.L., Dutrillaux B., and Poupon M.F. Clinical and experimental progression of a new model of human prostate cancer and therapeutic approach. Am. J. Pathol. 159 (2001) 753-764
20. Hurtado A., Pinos T., Barbosa-Desongles A., Lopez-Aviles S., Barquinero J., Petriz J., Santamaria-Martinez A., Morote J., de Torres I., Bellmunt J., Reventos J., and Munell F. Estrogen receptor beta displays cell cycle-dependent expression and regulates the G1 phase through a non-genomic mechanism in prostate carcinoma cells. Cell Oncol. 30 (2008) 349-365
21. Rowley D.R. What might a stromal response mean to prostate cancer progression?. Cancer Metastasis Rev. 17 (1998) 411-419
22. Olumi A.F., Grossfeld G.D., Hayward S.W., Carroll P.R., Tlsty T.D., and Cunha G.R. Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium. Cancer Res. 59 (1999) 5002-5011
23. Kalluri R., and Zeisberg M. Fibroblasts in cancer. Nature reviews 6 (2006) 392-401
24. Ronnov-Jessen L., Petersen O.W., and Bissell M.J. Cellular changes involved in conversion of normal to malignant breast: importance of the stromal reaction. Physiol. Rev. 76 (1996) 69-125
25. Galie M., Konstantinidou G., Peroni D., Scambi I., Marchini C., Lisi V., Krampera M., Magnani P., Merigo F., Montani M., Boschi F., Marzola P., Orru R., Farace P., Sbarbati A., and Amici A. Mesenchymal stem cells share molecular signature with mesenchymal tumor cells and favor early tumor growth in syngeneic mice. Oncogene 27 (2008) 2542-2551
26. Jonker J.W., Freeman J., Bolscher E., Musters S., Alvi A.J., Titley I., Schinkel A.H., and Dale T.C. Contribution of the ABC transporters Bcrp1 and Mdr1a/1b to the side population phenotype in mammary gland and bone marrow of mice. Stem Cells (Dayton, Ohio) 23 (2005) 1059-1065
27. Uchida N., Dykstra B., Lyons K., Leung F., Kristiansen M., and Eaves C. ABC transporter activities of murine hematopoietic stem cells vary according to their developmental and activation status. Blood 103 (2004) 4487-4495
28. Chamberlain G., Fox J., Ashton B., and Middleton J. Concise review: mesenchymal stem cells: their phenotype, differentiation capacity, immunological features, and potential for homing. Stem cells (Dayton, Ohio) 25 (2007) 2739-2749
29. Holmes C., and Stanford W.L. Concise review: stem cell antigen-1: expression, function, and enigma. Stem Cells (Dayton, Ohio) 25 (2007) 1339-1347
30. Wels J., Kaplan R.N., Rafii S., and Lyden D. Migratory neighbors and distant invaders: tumor-associated niche cells. Genes Dev. 22 (2008) 559-574
31. Karnoub A.E., Dash A.B., Vo A.P., Sullivan A., Brooks M.W., Bell G.W., Richardson A.L., Polyak K., Tubo R., and Weinberg R.A. Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature 449 (2007) 557-563
32. Lin V.K., Wang S.Y., Vazquez D.V., C C.X., Zhang S., and Tang L. Prostatic stromal cells derived from benign prostatic hyperplasia specimens possess stem cell like property. Prostate 67 (2007) 1265-1276
33. Ceder J.A., Jansson L., Ehrnstrom R.A., Ronnstrand L., and Abrahamsson P.A. The characterization of epithelial and stromal subsets of candidate stem/progenitor cells in the human adult prostate. Eur. Urol. 53 (2008) 524-531
34. Massague J. TGFbeta in Cancer. Cell 134 (2008) 215-230
35. Seoane J. Escaping from the TGFbeta anti-proliferative control. Carcinogenesis 27 (2006) 2148-2156
36. Maeda S., Hayashi M., Komiya S., Imamura T., and Miyazono K. Endogenous TGF-beta signaling suppresses maturation of osteoblastic mesenchymal cells. EMBO J. 23 (2004) 552-563
37. San Francisco I.F., DeWolf W.C., Peehl D.M., and Olumi A.F. Expression of transforming growth factor-beta 1 and growth in soft agar differentiate prostate carcinoma-associated fibroblasts from normal prostate fibroblasts. Int. J. Cancer 112 (2004) 213-218
38. Ao M., Franco O.E., Park D., Raman D., Williams K., and Hayward S.W. Cross-talk between paracrine-acting cytokine and chemokine pathways promotes malignancy in benign human prostatic epithelium. Cancer Res. 67 (2007) 4244-4253
39. Tuxhorn J.A., McAlhany S.J., Yang F., Dang T.D., and Rowley D.R. Inhibition of transforming growth factor-beta activity decreases angiogenesis in a human prostate cancer-reactive stroma xenograft model. Cancer Res. 62 (2002) 6021-6025
40. Bhowmick N.A., Chytil A., Plieth D., Gorska A.E., Dumont N., Shappell S., Washington M.K., Neilson E.G., and Moses H.L. TGF-beta signaling in fibroblasts modulates the oncogenic potential of adjacent epithelia. Science 303 (2004) 848-851
41. Kankuri E., Cholujova D., Comajova M., Vaheri A., and Bizik J. Induction of hepatocyte growth factor/scatter factor by fibroblast clustering directly promotes tumor cell invasiveness. Cancer Res. 65 (2005) 9914-9922
42. Hall B., Andreeff M., and Marini F. The participation of mesenchymal stem cells in tumor stroma formation and their application as targeted-gene delivery vehicles. Handb. Exp. Pharmacol. (2007) 263-283
43. Mishra P.J., Humeniuk R., Medina D.J., Alexe G., Mesirov J.P., Ganesan S., Glod J.W., and Banerjee D. Carcinoma-associated fibroblast-like differentiation of human mesenchymal stem cells. Cancer Res. 68 (2008) 4331-4339
44. Lepperdinger G., Brunauer R., Jamnig A., Laschober G., and Kassem M. Controversial issue: Is it safe to employ mesenchymal stem cells in cell-based therapies?. Exp. Gerontol. (2008)
45. Martin J., Helm K., Ruegg P., Varella-Garcia M., Burnham E., and Majka S. Adult lung side population cells have mesenchymal stem cell potential. Cytotherapy 10 (2008) 140-151
46. Yamahara K., Fukushima S., Coppen S.R., Felkin L.E., Varela-Carver A., Barton P.J., Yacoub M.H., and Suzuki K. Heterogeneic nature of adult cardiac side population cells. Biochem. Biophys. Res. Commun. 371 (2008) 615-620
47. Conrad C., Zeindl-Eberhart E., Moosmann S., Nelson P.J., Bruns C.J., and Huss R. Alkaline phosphatase, glutathione-S-transferase-P, and cofilin-1 distinguish multipotent mesenchymal stromal cell lines derived from the bone marrow versus peripheral blood. Stem Cells Dev. 17 (2008) 23-27
48. Motohashi N., Uezumi A., Yada E., Fukada S., Fukushima K., Imaizumi K., Miyagoe-Suzuki Y., and Takeda S. Muscle CD31(-) CD45(-) side population cells promote muscle regeneration by stimulating proliferation and migration of myoblasts. Am. J. Pathol. 173 (2008) 781-791
49. Kobayashi M., Yakuwa T., Sasaki K., Sato K., Kikuchi A., Kamo I., Yokoyama Y., and Sakuragawa N. Multilineage potential of side population cells from human amnion mesenchymal layer. Cell Transplant. 17 (2008) 291-301
50. Wu C., Wei Q., Utomo V., Nadesan P., Whetstone H., Kandel R., Wunder J.S., and Alman B.A. Side population cells isolated from mesenchymal neoplasms have tumor initiating potential. Cancer Res. 67 (2007) 8216-8222